Glenmede Trust’s BioMarin Pharmaceuticals BMRN Stock Holding History

Glenmede Trust’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$427K	Sell	7,552 -1,427	-16%	-$83.2K	﹤0.01%	1020
2025 Q4	$534K	Buy	+8,979	New	+$489K	﹤0.01%	917
2025 Q1	–	Sell	-3,636	Closed	-$239K	–	1383
2024 Q4	$239K	Buy	3,636 +22	+0.6%	+$1.47K	﹤0.01%	1182
2024 Q3	$254K	Buy	+3,614	New	+$302K	﹤0.01%	1158
2020 Q4	–	Sell	-537	Closed	-$40K	–	1343
2020 Q3	$40K	Buy	537 +76	+16%	+$7.69K	﹤0.01%	1385
2020 Q2	$56K	Buy	461 +147	+47%	+$14.6K	﹤0.01%	1284
2020 Q1	$26K	Hold	314	–	–	﹤0.01%	1947
2019 Q4	$26K	Hold	314	–	–	﹤0.01%	1947
2019 Q3	$21	Sell	314 -68	-18%	-$5.24K	﹤0.01%	2014
2019 Q2	$32	Buy	382 +40	+12%	+$3.42K	﹤0.01%	1882
2019 Q1	$30	Sell	342 -2	-0.6%	-$185	﹤0.01%	1913
2018 Q4	$29	Buy	+344	New	+$32.7K	﹤0.01%	1823
2018 Q3	–	Sell	-314	Closed	-$30K	–	1483
2018 Q2	$30K	Sell	314 -17,206	-98%	-$1.51M	﹤0.01%	1600
2018 Q1	$1.56M	Hold	17,520	–	–	0.01%	699
2017 Q4	$1.56M	Buy	17,520 +622	+4%	+$54.1K	0.01%	699
2017 Q3	$1.57M	Buy	16,898 +589	+4%	+$52K	0.01%	696
2017 Q2	$1.43M	Hold	16,309	–	–	0.01%	703
2017 Q1	$1.43M	Sell	16,309 -110	-0.7%	-$9.79K	0.01%	703
2016 Q4	$1.36M	Sell	16,419 -143	-0.9%	-$12.3K	0.01%	689
2016 Q3	$1.53M	Sell	16,562 -77	-0.5%	-$7.25K	0.01%	676
2016 Q2	$1.29M	Buy	16,639 +114	+0.7%	+$9.69K	0.01%	702
2016 Q1	$1.36M	Sell	16,525 -350	-2%	-$28.5K	0.01%	682
2015 Q4	$1.77M	Hold	16,875	–	–	0.01%	640
2015 Q3	$1.78M	Sell	16,875 -16	-0.1%	-$2.14K	0.01%	619
2015 Q2	$2.31M	Sell	16,891 -319	-2%	-$39.5K	0.02%	550
2015 Q1	$2.14M	Hold	17,210	–	–	0.02%	581
2014 Q4	$1.55M	Buy	17,210 +1,110	+7%	+$92.3K	0.01%	627
2014 Q3	$1.16M	Hold	16,100	–	–	0.01%	651
2014 Q2	$1M	Hold	16,100	–	–	0.01%	700
2014 Q1	$1.1M	Buy	16,100 +4,400	+38%	+$324K	0.01%	670
2013 Q4	$823K	Hold	11,700	–	–	0.01%	728
2013 Q3	$844K	Hold	11,700	–	–	0.01%	696
2013 Q2	$652K	Buy	+11,700	New	+$729K	0.01%	717